"Every donor, every time is medically screened prior to donation and every unit of blood collected by LifeSouth undergoes nine separate tests to screen for infectious diseases, and those tests are the most thorough and exacting possible, meeting all federal and industry standards," said LifeSouth General Counsel Kim Kinsell.
Kinsell said that, while she cannot comment specifically on the lawsuit, the chances of a patient contracting a disease from a tested unit of blood are extremely rare but testing does have its limits. The industry association AABB states current estimates are that fewer than 1 in 1.9 million blood components testing negative is capable of transmitting HIV.
She explained that there is a small window of time between a person contracting a disease and a test being able to detect it. "Scientifically, testing has narrowed that window considerably over the years, but it still exists," Kinsell said. "So, if a person donates within that window period of time, it would be impossible to detect the disease through testing."
According to the Centers for Disease Control, most people will develop detectable antibodies, detected by the most commonly used tests in the U.S., within two to eight weeks, with an average of within 25 days of their infection. The CDC also states that 97 percent of people will develop detectable antibodies in their first three months. Some individuals will take longer.
"In the past year we've had more than a quarter-million donors trust us to supply the blood for the patients in their communities. We've supplied more than 350,000 blood components to more than 110 hospitals in the Southeast, and every donor and every unit was tested," Kinsell said.
"The biggest danger we face is people not donating. Every day cancer and trauma patients and those undergoing surgery rely on that blood being there. Their lives literally depend on it. And every blood provider in the country uses the same testing as LifeSouth to assure that blood is safe," said LifeSouth President and CEO Nancy Eckert.